Evidence map›Paper›PMID 35948938›Full record

ArticleFluids and barriers of the CNS2022

Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters.

Sara Diana Lolansen, Nina Rostgaard, Dagne Barbuskaite, Tenna Capion, Markus Harboe Olsen, Nicolas H Norager, Frederik Vilhardt, Søren Norge Andreassen, Trine L Toft-Bertelsen, Fenghui Ye and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07662174 (VENTURE-PHH), which is not on this map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07662174 phase1 / phase2not yet recruitingnot on this mapstarted 2027, after this paper: background citation

VENTURE-PHH: Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage

TypeinterventionalSponsorMassachusetts General HospitalRan2027 to 2027Enrolled15ConditionsPost-hemorrhagic Hydrocephalus (PHH)ArmsSirolimus (Rapamune®)
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Aberrant adenosine ANature communications · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. The NaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Sara Diana Lolansen *Department of Neuroscience, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark.
Nina Rostgaard *Department of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Dagne BarbuskaiteDepartment of Neuroscience, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark.
Tenna CapionDepartment of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Markus Harboe OlsenDepartment of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Nicolas H NoragerDepartment of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Frederik VilhardtDepartment of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Søren Norge AndreassenDepartment of Neuroscience, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark.
Trine L Toft-BertelsenDepartment of Neuroscience, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark.
Fenghui YeDepartment of Neurosurgery, University of Michigan, Ann Arbor, USA.
Marianne JuhlerDepartment of Neurosurgery, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Richard F KeepDepartment of Neurosurgery, University of Michigan, Ann Arbor, USA.
Nanna MacAulayDepartment of Neuroscience, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark. macaulay@sund.ku.dk.ORCID http://orcid.org/0000-0002-7800-6600
University of Copenhagen · DKCopenhagen University Hospital · DKUniversity of Michigan · US

Funding

Carlsbergfondet CF19-0056Lundbeckfonden R276-2018-403Lundbeckfonden R303-2018-3005Novo Nordisk Fonden NNF17OC0024718The research council at Copenhagen University Hospital Rigshospitalet E-23565-03
6 · The paper itself

Abstract

introductionPosthemorrhagic hydrocephalus (PHH) often develops following hemorrhagic events such as intraventricular hemorrhage (IVH) and subarachnoid hemorrhage (SAH). Treatment is limited to surgical diversion of the cerebrospinal fluid (CSF) since no efficient pharmacological therapies are available. This limitation follows from our incomplete knowledge of the molecular mechanisms underlying the ventriculomegaly characteristic of PHH. Here, we aimed to elucidate the molecular coupling between a hemorrhagic event and the subsequent PHH development, and reveal the inflammatory profile of the PHH pathogenesis.

methodsCSF obtained from patients with SAH was analyzed for inflammatory markers using the proximity extension assay (PEA) technique. We employed an in vivo rat model of IVH to determine ventricular size, brain water content, intracranial pressure, and CSF secretion rate, as well as for transcriptomic analysis. Ex vivo radio-isotope assays of choroid plexus transport were employed to determine the direct effect of choroidal exposure to blood and inflammatory markers, both with acutely isolated choroid plexus and after prolonged exposure obtained with viable choroid plexus kept in tissue culture conditions.

resultsThe rat model of IVH demonstrated PHH and associated CSF hypersecretion. The Na

conclusionsCSF hypersecretion may contribute to PHH development, likely due to hyperactivity of choroid plexus transporters. The hemorrhage-induced inflammation detected in CSF and in the choroid plexus tissue may represent the underlying pathology. Therapeutic targeting of such pathways may be employed in future treatment strategies towards PHH patients.

Indexed as

HydrocephalusAnimalsBiomarkersCerebral HemorrhageChoroid PlexusInflammationRatsBiomarkersBiomarkersCerebrospinal fluidChoroid plexusImmune responseIntraventricular hemorrhagePosthemorrhagic hydrocephalusSubarachnoid hemorrhage

Identifiers

PMID35948938
PMCPMC9367104
OpenAlexW4291398628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.